/Companies

T-CURX

Würzburg, DE · 4 known investors

Find your way into T-CURX

Each arrow is one introduction. Sign up to fill in the first one.

186 people can intro you to Ulf

Ask Per Antonsson to introduce you to Ulf Grawunder

You →Per · together at University of Basel →Ulf

Sign up to find every way you can get introduced to T-CURX

  • Your email: who you already know at T-CURX, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the T-CURX team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

T-CURX is a venture-backed biotechnology company developing autologous CAR-T cell therapies using proprietary non-viral technologies, including in vivo and bedside-manufactured CAR-T approaches based on T cell-targeted LNP delivery of Sleeping Beauty transposon vectors. Its clinical pipeline targets cancers such as AML and CLL as well as cross-entity targets in hematological malignancies and solid tumors.

Founders & leadership

MHMichael Hudecek
Michael HudecekCo-founder
CR
Christoph RaderCo-founder & Member of the Scientific Advisory Board
UGUlf Grawunder
Ulf GrawunderCo-founder & CEOEntrepreneur in Residence at BioMedPartners

Investors · 4

Also in the syndicate · 1

BiomedVClead

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries ADec 2025

    BiomedVC (lead)

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does T-CURX do?
T-CURX is a venture-backed biotechnology company developing autologous CAR-T cell therapies using proprietary non-viral technologies, including in vivo and bedside-manufactured CAR-T approaches based on T cell-targeted LNP delivery of Sleeping Beauty transposon vectors. Its clinical pipeline targets cancers such as AML and CLL as well as cross-entity targets in hematological malignancies and solid tumors.
Who founded T-CURX?
T-CURX was founded by Michael Hudecek, Christoph Rader, Ulf Grawunder.
Who are T-CURX's investors?
T-CURX's investors include Highlight Capital, BioMedPartners, i&i Biotech Fund.
Where is T-CURX headquartered?
T-CURX is headquartered in Würzburg, DE.